Christopher Downs
2020
In 2020, Christopher Downs earned a total compensation of $791K as Chief Financial Officer at CNS Pharmaceuticals, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $94,700 |
|---|---|
| Option Awards | $396,299 |
| Salary | $300,000 |
| Total | $790,999 |
Downs received $396.3K in option awards, accounting for 50% of the total pay in 2020.
Downs also received $94.7K in non-equity incentive plan and $300K in salary.
Rankings
In 2020, Christopher Downs' compensation ranked 9,541st out of 13,090 executives tracked by ExecPay. In other words, Downs earned more than 27.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,541 out of 13,090 | 27th |
Division Manufacturing | 4,090 out of 5,617 | 27th |
Major group Chemicals And Allied Products | 1,668 out of 2,248 | 26th |
Industry group Drugs | 1,461 out of 1,948 | 25th |
Industry Pharmaceutical Preparations | 1,075 out of 1,453 | 26th |
Source: SEC filing on June 7, 2021.
Downs' colleagues
We found two more compensation records of executives who worked with Christopher Downs at CNS Pharmaceuticals in 2020.